Payment overview · 2025
General Payments
$50.92
1 reported records · 1 companies
Healthcare provider profile · identity verified
Prakash Machhar
Allopathic & Osteopathic Physicians|Internal Medicine · NEW PORT RICHEY, FL · NPI 1629127162
Verified facts
What the public records show
CMS Open Payments records show Prakash Machhar received $50.92 in general payments during 2025 across 1 reported records.
GENZYME CORPORATION accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GENZYME CORPORATION | Unresolved — no canonical attribution shown | $50.92 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $50.92 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 582 | 150 |
| Atorvastatin Calcium | Atorvastatin Calcium | 544 | 162 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 466 | 138 |
| Lisinopril | Lisinopril | 385 | 112 |
| Gabapentin | Gabapentin | 352 | 89 |
| Losartan Potassium | Losartan Potassium | 328 | 94 |
| Simvastatin | Simvastatin | 327 | 92 |
| Pantoprazole Sodium | Pantoprazole Sodium | 323 | 104 |
| Metformin Hcl | Metformin Hcl | 318 | 86 |
| Hydrochlorothiazide | Hydrochlorothiazide | 305 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 304 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 296 | 87 |
| Furosemide | Furosemide | 271 | 79 |
| Alprazolam | Alprazolam | 265 | 51 |
| Omeprazole | Omeprazole | 244 | 74 |
| Warfarin Sodium | Warfarin Sodium | 216 | 40 |
| Temazepam | Temazepam | 209 | 36 |
| Memantine Hcl | Memantine Hcl | 190 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 185 | 50 |
| Meloxicam | Meloxicam | 167 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 163 | 52 |
| Prednisone | Prednisone | 153 | 79 |
| Metoprolol Tartrate | Metoprolol Tartrate | 152 | 49 |
| Trazodone Hcl | Trazodone Hcl | 145 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 136 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 135 | 42 |
| Potassium Chloride | Potassium Chloride | 135 | 37 |
| Carvedilol | Carvedilol | 134 | 36 |
| Tramadol Hcl | Tramadol Hcl | 128 | 36 |
| Fluoxetine Hcl | Fluoxetine Hcl | 123 | 37 |
| Ropinirole Hcl | Ropinirole Hcl | 117 | 30 |
| Felodipine Er | Felodipine | 108 | 31 |
| Finasteride | Finasteride | 107 | 31 |
| Labetalol Hcl | Labetalol Hcl | 107 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 105 | 24 |
| Mirtazapine | Mirtazapine | 105 | 29 |
| Buspirone Hcl | Buspirone Hcl | 99 | 19 |
| Ibuprofen | Ibuprofen | 98 | 26 |
| Baclofen | Baclofen | 97 | 46 |
| Lorazepam | Lorazepam | 94 | 13 |
| Clonazepam | Clonazepam | 92 | 17 |
| Glipizide | Glipizide | 89 | 27 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 80 | 35 |
| Glimepiride | Glimepiride | 76 | 19 |
| Sertraline Hcl | Sertraline Hcl | 74 | 21 |
| Glipizide Er | Glipizide | 70 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 70 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 70 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 70 | 17 |
| Allopurinol | Allopurinol | 68 | 21 |
| Atenolol | Atenolol | 67 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 67 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 65 | 47 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 65 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 63 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 61 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 60 | 50 |
| Lovastatin | Lovastatin | 59 | 15 |
| Alendronate Sodium | Alendronate Sodium | 57 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 55 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 55 | 16 |
| Cephalexin | Cephalexin | 52 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 52 | 15 |
| Naproxen | Naproxen | 51 | 18 |
| Sildenafil Citrate | Sildenafil Citrate | 51 | 17 |
| Eliquis | Apixaban | 50 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 50 | 41 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 49 | 20 |
| Spironolactone | Spironolactone | 47 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 21 |
| Montelukast Sodium | Montelukast Sodium | 46 | 12 |
| Benazepril Hcl | Benazepril Hcl | 45 | 12 |
| Ezetimibe | Ezetimibe | 44 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 43 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 40 |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Methylprednisolone | Methylprednisolone | 39 | 27 |
| Digoxin | Digoxin | 38 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Lactulose | Lactulose | 34 | 12 |
| Levofloxacin | Levofloxacin | 34 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 32 | 11 |
| Primidone | Primidone | 32 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 26 |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 11 |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Metronidazole | Metronidazole | 26 | 24 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 24 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 23 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 22 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Jantoven | Warfarin Sodium | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | 17 |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 21 | suppressed |
| Famotidine | Famotidine | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Metolazone | Metolazone | 21 | 13 |
| Estradiol | Estradiol | 20 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 18 |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Sulindac | Sulindac | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $50.92 · 1 records | GENZYME CORPORATION | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error